FDA drug class

Insulin Analogs list

Every FDA-approved prescription drug the FDA NDC directory tags with the Insulin Analog [EPC] class, with brand names and DEA schedules.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

The FDA NDC directory lists 6 single-ingredient drugs in this class: insulin aspart, insulin degludec, insulin detemir, insulin glargine, insulin glulisine, insulin lispro. Another 2 combination products include one of them.

Run it in Rivvi

Map Novolog and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Insulin Analogs (8)

Insulin Analogs: FDA Insulin Analog class
DrugBrand namesTypeNDC listingsDEA schedule
Insulin aspartNovolog, Fiasp, NovoLog Mix 70/30Single ingredient35Not controlled
Insulin degludecTresibaSingle ingredient10Not controlled
Insulin detemirLevemirSingle ingredient1Not controlled
Insulin glargineLantus Solostar, LantusSingle ingredient22Not controlled
Insulin glulisineApidra, Apidra SoloStarSingle ingredient2Not controlled
Insulin lisproHumalog, Admelog, LyumjevSingle ingredient29Not controlled
Insulin degludec and liraglutideXultophy 100/3.6Combination1Not controlled
Insulin glargine and lixisenatideSoliqua 100/33Combination1Not controlled

FDA established pharmacologic class: Insulin Analog [EPC].

Questions

What drugs are Insulin Analogs?

The FDA NDC directory lists 6 single-ingredient drugs in this class: insulin aspart, insulin degludec, insulin detemir, insulin glargine, insulin glulisine, insulin lispro. Another 2 combination products include one of them.

Where does this list come from?

From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.

Related

Try it on your own data today.

Free to start. Most teams are using it the same day.